| Literature DB >> 30813599 |
Chenyu Wang1, Jun Wang2, Liangdan Zeng3, Ziwen Qiao4, Xiaochen Liu5, He Liu6, Jin Zhang7, Jianxun Ding8.
Abstract
Fiber structures with nanoscale diameters offer many fascinating features, such as excellent mechanical properties and high specific surface areas, making them attractive for many applications. Among a variety of technologies for preparing nanofibers, electrospinning is rapidly evolving into a simple process, which is capable of forming diverse morphologies due to its flexibility, functionality, and simplicity. In such review, more emphasis is put on the construction of polymer nanofiber structures and their potential applications. Other issues of electrospinning device, mechanism, and prospects, are also discussed. Specifically, by carefully regulating the operating condition, modifying needle device, optimizing properties of the polymer solutions, some unique structures of core⁻shell, side-by-side, multilayer, hollow interior, and high porosity can be obtained. Taken together, these well-organized polymer nanofibers can be of great interest in biomedicine, nutrition, bioengineering, pharmaceutics, and healthcare applications.Entities:
Keywords: application; electrospinning; fabrication; morphology; polymer nanofiber
Mesh:
Substances:
Year: 2019 PMID: 30813599 PMCID: PMC6429487 DOI: 10.3390/molecules24050834
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Some fabrication methods for nanofiber mats.
| Method | Advantages | Disadvantages | References |
|---|---|---|---|
| Phase separation | High porosity | Thin fibers and small pores | [ |
| Template synthesis | Designed fiber morphology | Low porosity | [ |
| Melt-blown | High efficiency, commercial | Instability, fiber diameter exceeding 1–2 μm | [ |
| Self-assembly | A simple route to synthesize multifunctional nanofibers | Introduction of the organic solvent | [ |
| 3D printing | Controlled pore size | Low porosity | [ |
| Electrospinning | Easy process and controlled fiber morphology | Small pores | [ |
Figure 1Possible structures and applications of electrospun fibers.
Figure 2The primary electrospinning apparatus and mechanism. (A) Schematic illustration of the typical electrospinning set-up; reproduced from [38] with permission from the Royal Society of Chemistry, Copyright 2014; (B) A diagram that shows the prototypical instantaneous position of the path of an electrospinning jet that contained three successive electrical bending instabilities; reproduced from [39] with permission from Elsevier Ltd, Copyright 2008.
Composition, solvent, concentration, and functionality and applications of polymer fibers.
| Composition | Solvent | Concentration | Functionality and Applications | References |
|---|---|---|---|---|
| Polymetylmethacrylate (PMMA) | Tetrahydrofuran (THF), acetone, chloroform | 10 wt% | Superhydrophobic units for active packaging | [ |
| Polyvinyl alcohol (PVA) | DI water | 8–16 wt% and 1–10 wt% | Biofilters and biomembranes | [ |
| Poly (lactic- | Polysorbate 80, ethanol/ethyl acetate | 4 wt% | Produced by a low-energy nano-emulsification approach, an easily scalable methodology, appropriate for the pharmaceutical industries | [ |
| Polycaprolactone (PCL) | Chloroform and acetone | 10% ( | Show great potential for further formulation as oromucosal drug delivery systems | [ |
| Poly (L-lactic acid) (PLLA) | 10 wt% | Sterilize PLLA membranes for clinical applications in regenerative medicine | [ | |
| Gelatin | DI water | 30–50% ( | For tissue regeneration, the versatility of this biomaterial | [ |
| Chitosan | Trifluoroacetic acid (TFA) | 1–6 wt% | Tissue engineering properties and wound healing | [ |
| Starch | Dimethyl sulfoxide (DMSO), glutaraldehyde | 25 wt% | Applications in the fields of tissue engineering, pharmaceutical therapy, and medical | [ |
| Collagen | TFA | 42.85% ( | Supports cell attachment and growth, form fibrous tissue engineering scaffolds | [ |
| PLGA-curcumin | Chloroform/methanol | 40 wt%/60 wt% | Delivering curcumin over a long period in a controlled manner | [ |
| PLGA–collagen | Hexafluoroiso-propanol (HFIP) | 20% ( | For bioengineered skin substitutes | [ |
| PCL–chitosan | HFIP and acetic acid | 20:1 ( | The fast degradation profile leads to rapid cellular infiltration, improved vascular remodeling, and neotissue formation without calcification or aneurysm | [ |
| Poly(ε-hydroxybutyrate- | Tetrafluoro-ethylene (TFE) | 50 wt% | Serves as a useful alternative carrier for ocular surface tissue engineering and use as an alternative substrate to amniotic membrane | [ |
| Hydroxyapatite (HAP)–tussah silk fibroin | Ammonia, citric acid | 31 wt% | Supply as scaffolds in tissue engineering and bone regeneration | [ |
| Poly(lactic acid) (PLA)/PCL–cellulose nanocrystals | Acetone, DCM, toluene with phosphorus pentoxide | 1wt% | Biodegradable character, use in different areas such as biomedicine or food packaging | [ |
| PVA/alginate-bioglass | DI water | 10 wt% | With proper biological and mechanical properties for soft/hard tissue applications | [ |
| Polycatecholamine/CaCO3-collagen | HFIP, CaCl2 solution | 8% ( | Provide multifunctional scaffold properties for possible bone tissue engineering applications | [ |
| PCL/(polyvinylpyrrolidone) PVP- | Chloroform: methanol | 10% ( | Promoting in vitro osteoblast differentiation, we can help with site-specific repair and regeneration of bone tissue | [ |
| Polyurethane (PU)–dextran–estradiol | DMSO and THF | 10 wt% | Post-menopausal wound dressing | [ |
| PVA–PVP–HAP | DMSO | 2.5, 5, 8.5, 10, and 15 wt% | Sensor, anti-static, microwave absorbing, and conductive coating | [ |
| PLGA–tussah silk–graphene oxide | HFIP | 13 wt% | Cancer treatment, therapeutic patch for drug delivery, and an excellent scaffold material for bone tissue engineering | [ |
| Polyvinylidene fluoride (PVDF)–graphene oxide–silver | Acetone and DMF | 2 wt% | Micro and nanoscale magnetoelectric devices, magnetic-field sensors, and energy-harvesters | [ |
| Poly (ε-caprolactone)–cellulose acetate–dextran–tetracycline hydrochloride | DMF, THF | 10 wt% | Good bioactivity, high cell attachment and proliferation, effective antibiotic activity against bacteria, for wound dressing and skin engineering applications | [ |
Figure 3Fabrication techniques of bioactive electrospun scaffolds (A) physical adsorption; (B) blend electrospinning; (C) coaxial electrospinning; (D) covalent immobilization. Reproduced from [79] with permission from Springer Nature; Copyright 2008.
Figure 4A schematic diagram of the modified electrospinning set-up. Reproduced from [145] with permission from Elsevier Ltd.; Copyright 2008. Reproduced from [146] with permission from Future Science Group; Copyright 2012. Reproduced from [140] with permission from Elsevier Ltd.; Copyright 2005. Reproduced from [129] with permission from Elsevier Ltd.; Copyright 2005. Reproduced from [147] with permission from Hindawi; Copyright 2011.
Figure 5Melt electrospun scaffolds and their effects on human hematopoietic stem cells. (A) Melt electrospun PCL scaffolds. (B) Scanning electron microscopy (SEM) image of primary human osteoblasts on scaffolds in osteogenic conditions. (C) Cross-section profiles of scaffolds seeded with primary human osteoblasts in osteogenic conditions. (D–G) The expression of (D) fibronectin (FN), (E) vitronectin (VN), (F) Alkaline phosphatase (ALP), and (G) osteopontin (OPN) by primary human osteoblasts in osteogenic conditions. (H) Confocal microscopy showed that CD45+ cells (green) attached and migrated into primary human osteoblast-seeded scaffolds using osteogenic conditions (red); cell nuclei in blue. Reproduced from [154] with permission from Elsevier Ltd.; Copyright 2017.
Figure 6Preparation and characterization of dexamethasone (DEX) and bone morphogenetic protein-2 (BMP-2) co-loaded emulsion electrospun nanofibers and their effects on human mesenchymal stem cells (hMSCs). (A) Preparation of poly(L-lactide-co-caprolactone) (PLLACL) emulsion electrospun nanofibers with DEX in the shell and BMP-2 in the core. (B) Fluorescence microscopic image and transmission electron microscopy (TEM) image of the nanofibers. (C) Release profiles of bovine serum albumin (BSA) and DEX from the nanofibers. Reproduced from [180] with permission from Elsevier Ltd.; Copyright 2012.
Figure 7Preparation and characterization of electrospinning nanofibers with hollow structures. (A) Schematic illustration of the electrospinning setup for hollow structure nanofibers. (B) TEM image of the hollow fibers. The walls of these tubes were composed of amorphous TiO2 and PVP. (C) TEM image of TiO2 hollow nanofibers that were obtained by calcining the composite tubes in the air at 500 °C. (D) SEM image of TiO2 hollow fibers that were in a uniaxially aligned array. Reproduced from [198] with permission from the American Chemical Society; Copyright 2004.
Figure 8Preparation and characterization of electrospinning fibers with porous structure. (A) Schematic illustration of the electrospinning chamber for porous structure microfibers. (B) Schematic diagram showing the formation of pores during electrospinning. (C) SEM images of the electrospun PMMA fibers obtained at polymer concentrations of (a) 12, (b) 15, (c) 18, and (d) 21 wt% and at a humidity of 25%. Reproduced from [214] with permission from Springer Nature; Copyright 2013.
Figure 9Structure and central performance characterization of multilayer electronic device. (A) Illustration of the overall components of the piezoelectric device with microscopic photographs of the microbead array. (B) Cross-sectional images of the vacuum-packed devices with P-DB5 and an SEM image of the electrospun nanofiber mat. (C) Relationship between the output performances of voltage and current varied by the applied pressure using the device with P-DB5. (D) Output signals of the drop test results using a small leaf, a grain of rice, and a water droplet. Reproduced from [227] with permission from the American Chemical Society; Copyright 2018.
Figure 10Fabrication, morphology, and mechanism of side-by-side structures. (A) Side-by-side electrospinning process: (a) experimental apparatus (inset: connection of side-by-side spinneret with the working fluids and power supply); (b) a photograph of a typical side-by-side electrospinning process with the Teflon-coated spinneret; (c) a Janus Taylor cone formed with the Teflon-coated spinneret; (d) fiber mat from side-by-side electrospinning with uncoated side-by-side spinneret; (e) the separation of fluids when using the uncoated spinneret; (f) an illustration of the role played by the Teflon coating: A—the separation of fluids arising from repulsive forces Ft (between the two Taylor cones), Fs (between the two straight fluid jets). (B) TEM images of (a) F3; (b) F4; (c) F5; (d) F6 and Fc (between the two coils); and B—the formation of an integrated Janus Taylor cone with the Teflon coating. (C) Field emission scanning electron microscope (FESEM) images of the fibers remaining after 24 h of dissolution and the proposed drug release mechanism. (a–d) show the remains of fibers F3–F6 respectively; (D) is a schematic diagram explaining the mechanism of drug release from the Janus fibers. Reproduced from [236] with permission from Elsevier Ltd.; Copyright 2016.